188 related articles for article (PubMed ID: 7534667)
1. The blood B-cells and bone marrow plasma cells in patients with multiple myeloma share identical IgH rearrangements.
Bergsagel PL; Masellis Smith A; Belch AR; Pilarski LM
Curr Top Microbiol Immunol; 1995; 194():17-24. PubMed ID: 7534667
[TBL] [Abstract][Full Text] [Related]
2. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction.
Szczepek AJ; Seeberger K; Wizniak J; Mant MJ; Belch AR; Pilarski LM
Blood; 1998 Oct; 92(8):2844-55. PubMed ID: 9763569
[TBL] [Abstract][Full Text] [Related]
3. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
[TBL] [Abstract][Full Text] [Related]
4. CD34+ cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements.
Szczepek AJ; Bergsagel PL; Axelsson L; Brown CB; Belch AR; Pilarski LM
Blood; 1997 Mar; 89(5):1824-33. PubMed ID: 9057669
[TBL] [Abstract][Full Text] [Related]
5. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
[TBL] [Abstract][Full Text] [Related]
6. Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry.
Conway EJ; Wen J; Feng Y; Mo A; Huang WT; Keever-Taylor CA; Hari P; Vesole DH; Chang CC
Arch Pathol Lab Med; 2009 Oct; 133(10):1594-9. PubMed ID: 19792049
[TBL] [Abstract][Full Text] [Related]
7. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
[TBL] [Abstract][Full Text] [Related]
8. In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes.
Rasmussen T; Lodahl M; Hancke S; Johnsen HE
Leuk Lymphoma; 2004 Jul; 45(7):1413-7. PubMed ID: 15359642
[TBL] [Abstract][Full Text] [Related]
9. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.
Billadeau D; Ahmann G; Greipp P; Van Ness B
J Exp Med; 1993 Sep; 178(3):1023-31. PubMed ID: 8350044
[TBL] [Abstract][Full Text] [Related]
10. Improvement of clonality detection rate in multiple myeloma using fluorescent IgH PCR with different sets of primers.
Welterlin V; Debecker A; Tschieb D; Zanetti C; Lange W; Hénon PR
J Hematother Stem Cell Res; 2000 Dec; 9(6):983-91. PubMed ID: 11177613
[TBL] [Abstract][Full Text] [Related]
11. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells.
Sakai A; Fujii T; Noda M; Hyodo H; Oda K; Kimura A
Am J Hematol; 1996 Dec; 53(4):251-3. PubMed ID: 8948665
[TBL] [Abstract][Full Text] [Related]
12. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
Thiago LS; Perez-Andres M; Balanzategui A; Sarasquete ME; Paiva B; Jara-Acevedo M; Barcena P; Sanchez ML; Almeida J; González M; San Miguel JF; Garcia-Sanz R; Orfao A
Haematologica; 2014 Jan; 99(1):155-62. PubMed ID: 23872308
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines.
Commes T; Clofent G; Ghanem N; Zhang XG; Lefranc MP; Bataille R; Klein B
Leukemia; 1993 Apr; 7(4):609-17. PubMed ID: 7681918
[TBL] [Abstract][Full Text] [Related]
15. Sequential maturation stages of monoclonal B lineage cells from blood, spleen, lymph node, and bone marrow from a terminal myeloma patient.
Jensen GS; Mant MJ; Pilarski LM
Am J Hematol; 1992 Nov; 41(3):199-208. PubMed ID: 1384318
[TBL] [Abstract][Full Text] [Related]
16. Identification of clonotypic IgH VDJ sequences in multiple myeloma.
Taylor BJ; Kriangkum J; Strachan ER; Wizniak J; Pilarski LM
Methods Mol Med; 2005; 113():121-44. PubMed ID: 15968099
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.
McSweeney PA; Wells DA; Shults KE; Nash RA; Bensinger WI; Buckner CD; Loken MR
Blood; 1996 Jul; 88(2):622-32. PubMed ID: 8695810
[TBL] [Abstract][Full Text] [Related]
18. Analysis of tumor specific immunoglobulin gene rearrangement in peripheral blood B-cells of multiple myeloma patients by a PCR-SSCP method.
Wu S; Wang L; Wang Y; Zhu P; Xie G
Chin Med J (Engl); 1997 Sep; 110(9):682-5. PubMed ID: 9642324
[TBL] [Abstract][Full Text] [Related]
19. Circulating clonal lymphocytes in myeloma determined by mRNA in situ hybridization.
Joshua DE; Brown RD; Luo XF; Gibson J
Blood; 1996 Aug; 88(3):1125. PubMed ID: 8704226
[No Abstract] [Full Text] [Related]
20. Continuing immunoglobulin heavy chain gene rearrangements in chronic myeloid leukemia with recurrent B-lymphoid blast crises after bone marrow transplantation.
Kiyoi H; Fukutani H; Yamauchi T; Kubo K; Ohno R; Yamamori S; Naoe T
Leukemia; 1995 Feb; 9(2):265-70. PubMed ID: 7869762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
